Key result
Echocardiographic epicardial adipose tissue thickness measured during the early second trimester was significantly associated with an increased risk of gestational diabetes mellitus (OR 2.87).
Why the study?
Gestational diabetes mellitus carries long-term risks of maternal and neonatal comorbidities, but the predictive role of echocardiographic epicardial adipose tissue in the early second trimester needed investigation.
Does increased echocardiographic epicardial adipose tissue thickness predict gestational diabetes mellitus in pregnant women?
Cohort (n=2,146)
No
Does increased echocardiographic epicardial adipose tissue thickness predict gestational diabetes mellitus in pregnant women?
Odds Ratio: 2.87 (95% CI 2.49–3.31)
p-value: p=<0.001
Echocardiographic epicardial adipose tissue thickness measured in the early second trimester is a significant and independent predictor of gestational diabetes mellitus and its associated adverse neonatal outcomes.
BACKGROUND: Gestational diabetes mellitus (GDM) is the most common metabolic disorder that can occur during pregnancy and is associated with a long-term risk of both maternal and neonatal comorbidities. This study aimed to investigate the association between echocardiographic epicardial adipose tissue (EAT) and the risk for GDM during the early second trimester of pregnancy. METHOD: We recruited all singleton pregnancies between January 2014 and December 2018 at 16 weeks + 0 days to 19 weeks + 6 days. We then used generalized linear models to calculate odds ratios (ORs) and 95% confidence intervals (CIs) for EAT as a potential predictor for GDM. Receiver-operating-characteristic (ROC) analysis was then conducted to investigate the discriminative capacity of any individual maternal factor for the prediction of GDM. RESULTS: In total, our study involved 314 pregnant women with GDM and 1832 pregnant women without GDM. Multivariate regression analysis revealed that EAT thickness (OR = 2.87; 95% CI: 2.49-3.31) was significantly associated with the presence of GDM (P < 0.001). Furthermore, EAT thickness was also significantly associated with a range of adverse outcomes in the GDM group, including large size for gestational age, neonatal hypoglycemia, admission to the neonatal intensive care unit, preterm delivery, and hyperbilirubinemia (P < 0.001). ROC analysis revealed that the area under the curve was 0.790 (95% CI: 0.768-0.812). When the cutoff value for EAT thickness was set to 5.49 mm, the sensitivity was 95.2% and the specificity was 50.5%. CONCLUSIONS: Echocardiographic EAT thickness is positively and significantly associated with both the risk of GDM and adverse outcomes related to GDM. Echocardiographic EAT has the potential to predict GDM prior to actual clinical diagnosis.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2020) conducted a cohort in Gestational diabetes mellitus (n=2,146). Epicardial adipose tissue (EAT) thickness vs. Lower EAT thickness was evaluated on Presence of gestational diabetes mellitus (GDM) (OR 2.87, 95% CI 2.49-3.31, p=<0.001). Echocardiographic epicardial adipose tissue thickness measured during the early second trimester was significantly associated with an increased risk of gestational diabetes mellitus (OR 2.87).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: